GENEVA, Aug. 14 -- THE UNIVERSITY OF OSAKA filed a patent application (JP2026/000503) for “PHARMACEUTICAL COMPOSITION FOR TREATING DISEASES ASSOCIATED WITH ENHANCED FUNCTION OF FIBROBLAST GROWTH FACTOR RECEPTOR 3”. With publication no. WO/2026/168087, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 45/00
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....